Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patients
- 29 January 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 90 (5), 547-548
- https://doi.org/10.1002/bjs.4068
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip ArthroplastyArchives of Internal Medicine, 2001
- Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgeryBritish Journal of Surgery, 2001
- Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and SafetyChest, 2001
- Factor V Leiden and Morbid Obesity in Fatal Postoperative Pulmonary EmbolismArchives of Surgery, 2000
- Current Practices in the Prophylaxis of Venous Thromboembolism in Bariatric SurgeryObesity Surgery, 2000
- Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparinsBritish Journal of Haematology, 1999
- Prediction of Deep Vein Thrombosis after Elective Hip Replacement Surgery by Preoperative Clinical and Haemostatic Variables: The ECAT DVT StudyThrombosis and Haemostasis, 1999
- Still missing the boat with fatal pulmonary embolismBritish Journal of Surgery, 1996